Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

LL-37

Cathelicidin, hCAP-18, FALL-39, CAP-18

Quick Stats
Studies 2230
Trials 95
Score 2
2008 pubmed

The host defense peptide LL-37 selectively permeabilizes apoptotic leukocytes.

Björstad. Ase A; Askarieh. Galia G; Brown. Kelly L KL; Christenson. Karin K; Forsman. Huamei H; Onnheim. Karin K; Li. Hsin-Ni HN; Teneberg. Susann S; Maier. Olaf O; Hoekstra. Dick D; Dahlgren. Claes C; Davidson. Donald J DJ; Bylund. Johan J

Key Findings

  • LL-37 selectively permeabilizes apoptotic leukocytes but spares viable cells
  • The permeabilization is rapid, receptor‑independent, and blocked by serum HDL
  • In neutrophils, LL-37 releases both cytoplasmic (LDH) and granule (myeloperoxidase) contents, potentially altering inflammatory signals

Practical Outcomes

  • For biohackers, the study mainly provides safety insight: high levels of LL-37 could affect immune cell turnover and inflammation. It isn’t a direct protocol for longevity or performance, but suggests that any self‑experimentation with LL‑37 or similar peptides should consider dose‑dependent immune effects and possible interference by blood lipids.

Summary

LL-37 is a natural antimicrobial peptide that not only kills bacteria but also can poke holes in the membranes of dying immune cells (apoptotic leukocytes) while leaving healthy cells alone. This effect happens quickly, doesn’t need cell receptors, and can be blocked by components in blood like HDL. The finding hints that LL-37 might help clear out dead immune cells and influence inflammation, but it isn’t a ready‑to‑use supplement for everyday health hacks.

Abstract

LL-37 is a cationic host defense peptide that is highly expressed during acute inflammation and that kills bacteria by poorly defined mechanisms, resulting in permeabilization of microbial membranes. High concentrations of LL-37 have also been reported to have cytotoxic effects against eukaryotic cells, but the peptide is clearly capable of differentiating between membranes with different compositions (eukaryotic versus bacterial membranes). Eukaryotic cells such as leukocytes change their membrane composition during apoptotic cell death, when they are turned into nonfunctional but structurally intact entities. We tested whether LL-37 exerted specific activity on apoptotic cells and found that the peptide selectively permeabilized the membranes of apoptotic human leukocytes, leaving viable cells unaffected. This activity was seemingly analogous to the direct microbicidal effect of LL-37, in that it was rapid, independent of known surface receptors and/or active cell signaling, and inhibitable by serum components such as high-density lipoprotein. A similar selective permeabilization of apoptotic cells was recorded for both NK cells and neutrophils. In the latter cell type, LL-37 permeabilized both the plasma and granule membranes, resulting in the release of both lactate dehydrogenase and myeloperoxidase. Apoptosis is a way for inflammatory cells to die silently and minimize collateral tissue damage by retaining tissue-damaging and proinflammatory substances within intact membranes. Permeabilization of apoptotic leukocytes by LL-37, accompanied by the leakage of cytoplasmic as well as intragranular molecules, may thus shift the balance between pro- and anti-inflammatory signals and in this way be of importance for the termination of acute inflammation.

Study Information

Provider

pubmed

Year

2008

Date

2008-12-15T00:00:00.000Z

DOI

10.1128/aac.01310-08